Jyrki A Kettunen1, Urho M Kujala2, Jaakko Kaprio3, Heli Bäckmand4, Markku Peltonen5, Johan G Eriksson6, Seppo Sarna7. 1. Arcada University of Applied Sciences, Helsinki, Finland. 2. Department of Health Sciences, University of Jyväskylä, Jyväskylä, Finland. 3. Department of Public Health, University of Helsinki, Hjelt Institute, Helsinki, Finland Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland University of Helsinki, Institute for Molecular Medicine (FIMM), Helsinki, Finland. 4. Health and Social Welfare Department, City of Vantaa, Finland. 5. Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland. 6. Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland Vasa Central Hospital, Vasa, Finland Folkhälsan Research Centre, Helsinki, Finland Unit of General Practice, Helsinki University Central Hospital, Helsinki, Finland. 7. Department of Public Health, University of Helsinki, Hjelt Institute, Helsinki, Finland.
Abstract
AIM: To investigate life expectancy and mortality among former elite athletes and controls. METHODS: HR analysis of cause-specific deaths sourced from the national death registry for former Finnish male endurance, team and power sports athletes (N=2363) and controls (N=1657). The median follow-up time was 50 years. RESULTS: Median life expectancy was higher in the endurance (79.1 years, 95% CI 76.6 to 80.6) and team (78.8, 78.1 to 79.8) sports athletes than in controls (72.9, 71.8 to 74.3). Compared to controls, risk for total mortality adjusted for socioeconomic status and birth cohort was lower in the endurance ((HR 0.70, 95% CI 0.61 to 0.79)) and team (0.80, 0.72 to 0.89) sports athletes, and slightly lower in the power sports athletes (0.93, 0.85 to 1.03). HR for ischaemic heart disease mortality was lower in the endurance (0.68, 0.54 to 0.86) and team sports (0.73, 0.60 to 0.89) athletes. HR for stroke mortality was 0.52 (0.33 to 0.83) in the endurance and 0.59 (0.40 to 0.88) in the team sports athletes. Compared to controls, the risk for smoking-related cancer mortality was lower in the endurance (HR 0.20, 0.08 to 0.47) and power sports (0.40, 0.25 to 0.66) athletes. For dementia mortality, the power sports athletes, particularly boxers, had increased risk (HR 4.20, 2.30 to 7.81). CONCLUSIONS: Elite athletes have 5-6 years additional life expectancy when compared to men who were healthy as young adults. Lower mortality for cardiovascular disease was in part due to lower rates of smoking, as tobacco-related cancer mortality was especially low. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
AIM: To investigate life expectancy and mortality among former elite athletes and controls. METHODS: HR analysis of cause-specific deaths sourced from the national death registry for former Finnish male endurance, team and power sports athletes (N=2363) and controls (N=1657). The median follow-up time was 50 years. RESULTS: Median life expectancy was higher in the endurance (79.1 years, 95% CI 76.6 to 80.6) and team (78.8, 78.1 to 79.8) sports athletes than in controls (72.9, 71.8 to 74.3). Compared to controls, risk for total mortality adjusted for socioeconomic status and birth cohort was lower in the endurance ((HR 0.70, 95% CI 0.61 to 0.79)) and team (0.80, 0.72 to 0.89) sports athletes, and slightly lower in the power sports athletes (0.93, 0.85 to 1.03). HR for ischaemic heart disease mortality was lower in the endurance (0.68, 0.54 to 0.86) and team sports (0.73, 0.60 to 0.89) athletes. HR for stroke mortality was 0.52 (0.33 to 0.83) in the endurance and 0.59 (0.40 to 0.88) in the team sports athletes. Compared to controls, the risk for smoking-related cancer mortality was lower in the endurance (HR 0.20, 0.08 to 0.47) and power sports (0.40, 0.25 to 0.66) athletes. For dementia mortality, the power sports athletes, particularly boxers, had increased risk (HR 4.20, 2.30 to 7.81). CONCLUSIONS: Elite athletes have 5-6 years additional life expectancy when compared to men who were healthy as young adults. Lower mortality for cardiovascular disease was in part due to lower rates of smoking, as tobacco-related cancer mortality was especially low. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Authors: Fabian Sanchis-Gomar; Laura M Pérez; Michael J Joyner; Herbert Löllgen; Alejandro Lucia Journal: Sports Med Date: 2016-04 Impact factor: 11.136
Authors: Merja K Laine; Johan G Eriksson; Urho M Kujala; Rahul Raj; Jaakko Kaprio; Heli M Bäckmand; Markku Peltonen; Seppo Sarna Journal: J Sports Sci Med Date: 2015-05-08 Impact factor: 2.988
Authors: Trude E Robsahm; Ragnhild S Falk; Trond Heir; Leiv Sandvik; Linda Vos; Jan E Erikssen; Steinar Tretli Journal: Cancer Med Date: 2016-05-26 Impact factor: 4.452